Mingying Xie
548 Binwen Road
Hangzhou, China
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Survival and prognostic factors of HER2-mutant advanced non-small cell lung cancer with brain metastases.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 22, 2024
Efficacy of immunotherapy in RET fusion-positive NSCLC: A meta-analysis.
Journal: Heliyon
Published: January 16, 2024
Serum cytokine analysis in a cohort of advanced non-small cell lung cancer treated with PD-1 inhibitors reveals predictive markers of CXCL12.
Journal: Frontiers in immunology
Published: March 26, 2023
LncRNAs and related molecular basis in malignant pleural mesothelioma: Challenges and potential.
Journal: Critical reviews in oncology/hematology
Published: December 30, 2022
Real-world treatment and prognostic factors for survival in ALK+ non-small cell lung cancer (NSCLC) patients with brain metastases in China.
Journal: Thoracic cancer
Published: September 18, 2022
ASO Author Reflection: The TME-Related Gene AIF1 Signature Predicts Esophageal Carcinoma Prognosis.
Journal: Annals of surgical oncology
Published: October 05, 2021
The Novel Tumor Microenvironment-Related Prognostic Gene AIF1 May Influence Immune Infiltrates and is Correlated with TIGIT in Esophageal Cancer.
Journal: Annals of surgical oncology
Published: August 02, 2021
Efficacy of PD-1/PD-L1 inhibitors in patients with non-small cell lung cancer and brain metastases: A real-world retrospective study in China.
Journal: Thoracic cancer
Published: June 11, 2021
KRAS-Mutant Non-Small Cell Lung Cancer: An Emerging Promisingly Treatable Subgroup.
Journal: Frontiers in oncology
Published: February 26, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026